Showing results (401-410 of 5,696) with videos related to

Sort By:
Pageof 570
Medical Oncology (Northwood, London, England)|February 2, 2019
Real-world outcomes in patients with unresected stage III non-small cell lung cancerKellie J Ryan, Karen E Skinner, Ancilla W Fernandes, et al.
Medical Oncology (Northwood, London, England)|February 4, 2019
Metastatic castration resistant prostate cancer with squamous cell, small cell, and sarcomatoid elements-a clinicopathologic and genomic sequencing-based discussionSteven C Weindorf, Alexander S Taylor, Chandan Kumar-Sinha, et al.
Medical Oncology (Northwood, London, England)|January 23, 2019
Risk factors, clinical outcomes, and natural history of uveal melanoma: a single-institution analysisGlenda M Delgado-Ramos, Fridtjof Thomas, Ari VanderWalde, et al.
Medical Oncology (Northwood, London, England)|December 28, 2019
Adult soft tissue myoepithelial carcinoma: treatment outcomes and efficacy of chemotherapyFlorence Chamberlain, Elena Cojocaru, Mariana Scaranti, et al.
Medical Oncology (Northwood, London, England)|March 7, 2018
Seven-month prostate-specific antigen (PSA) is prognostic in patients with prostate cancer initially diagnosed with distant metastasesCarsten Nieder, Ellinor Haukland, Adam Pawinski, et al.
Medical Oncology (Northwood, London, England)|March 8, 2018
Intravenous versus oral etoposide: efficacy and correlation to clinical outcome in patients with high-grade metastatic gastroenteropancreatic neuroendocrine neoplasms (WHO G3)Abir Salwa Ali, Malin Grönberg, Seppo W Langer, et al.
Medical Oncology (Northwood, London, England)|February 22, 2018
Knockdown of STEAP1 inhibits cell growth and induces apoptosis in LNCaP prostate cancer cells counteracting the effect of androgensInês Margarida Gomes, Sandra Moreira Rocha, Carlos Gaspar, et al.
Medical Oncology (Northwood, London, England)|July 6, 2016
Targeting tumor hypoxia with the epigenetic anticancer agent, RRx-001: a superagonist of nitric oxide generationMarcel H Fens, Pedro Cabrales, Jan Scicinski, et al.
Medical Oncology (Northwood, London, England)|July 15, 2017
Validity of neoadjuvant chemotherapy with docetaxel, cisplatin, and S-1 for resectable locally advanced gastric cancerKinro Sasaki, Shinichi Onodera, Kichiro Otsuka, et al.
Medical Oncology (Northwood, London, England)|November 23, 2017
Factors for time to trastuzumab-induced cardiotoxicity in breast cancer patientsMi Hyung Lee, Jeong Yee, Young Ju Kim, et al.
Pageof 570